Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Celgene halts Revlimid ORIGIN trial due to deaths
Yahoo/Fly on the Wall
Thursday, July 18, 2013 - 9:50am
tags:
clinical trials, Celgene, Revlimid, chronic lymphocytic leukemia
Could China scandal derail Glaxo?
CNN Money
Thursday, July 18, 2013 - 9:48am
tags:
GSK, China
Feds Probe Novartis Over Marketing Of Its Gilenya MS Pill
Pharmalot
Thursday, July 18, 2013 - 9:33am
tags:
Novartis, MS, multiple sclerosis, Gilenya
Unilife: Taking Positions Ahead Of A Key Fiscal Year
Seeking Alpha
Thursday, July 18, 2013 - 9:32am
tags:
Unilife, Biodel
J&J Agrees to Pay $22.9 Million to Settle on Drug Recalls
Bloomberg
Thursday, July 18, 2013 - 9:09am
tags:
JNJ, recalls
Eli Lilly to freeze employee base pay ahead of generic onslaught
Yahoo/Reuters
Wednesday, July 17, 2013 - 10:52pm
tags:
Eli Lilly, generics
Teva reveals CEO pay secret: Levin collected $4.1M in 2012
Fierce Pharma
Wednesday, July 17, 2013 - 12:45pm
tags:
Teva, Jeremy Levin, executive pay
5 Speculative Biotech Stocks With Catalysts Pending: Revisited
Seeking Alpha
Wednesday, July 17, 2013 - 12:42pm
tags:
NewLink Genetics, OncoSec Medical, Arqule, Raptor Pharmaceuticals, Zogenix
Celgene Seen Widening Products Beyond Revlimid
Investors.com
Wednesday, July 17, 2013 - 12:40pm
tags:
Celgene, Revlimid
4 Reasons This Biotech Went up by 400 Percent
Motley Fool
Wednesday, July 17, 2013 - 12:36pm
tags:
Celldex, Alexion, Roche
Soligenix Readies 2 Drugs For Key Trials This Year
Seeking Alpha
Wednesday, July 17, 2013 - 12:34pm
tags:
Soligenix, SGX203
Abbott's Winning (Baby) Formula for Success. Are There More Spinoffs to Come? Comment Now Follow Comments
Forbes
Wednesday, July 17, 2013 - 12:33pm
tags:
Abbott Laboratories, spinoffs, AbbVie, nutrition, infant nutrition
Vaccine-focused Pfizer licenses out TB drug
Pharma Times, UK
Wednesday, July 17, 2013 - 11:24am
tags:
Pfizer, vaccines, tuberculosis, Sequella
How Much? Novartis Gives Vasella $25,000 A Day For Consulting
Pharmalot
Wednesday, July 17, 2013 - 11:22am
tags:
Daniel Vasella, Novartis
J&J Pays $23M To Settle Class Action Suit Over OTC Troubles
Pharmalot
Wednesday, July 17, 2013 - 11:10am
tags:
OTC, JNJ
Court finds in favor of Mylan in patent suit related to Teva's Copaxone patents
The Fly on the Wall
Wednesday, July 17, 2013 - 11:06am
tags:
Mylan, Teva Pharmaceuticals, Copaxone, patents
Will Payments To Scientists For New Drugs Improve GSK's R&D Productivity?
Forbes
Wednesday, July 17, 2013 - 11:03am
tags:
GSK, R&D
China blocks GSK finance head from leaving country
Yahoo/Reuters
Wednesday, July 17, 2013 - 11:02am
tags:
GSK, China
Ventrus Poised For Run-Up Ahead Of Phase III Results
Seeking Alpha
Wednesday, July 17, 2013 - 11:01am
tags:
Ventrus, VEN 307
3 Potential Game Changers for COPD
Motley Fool
Wednesday, July 17, 2013 - 10:59am
tags:
COPD, Anoro, GSK, Theravance, QVA149, Novartis, olodaterol, Boehringer Ingelheim, Pfizer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.